(CercleFinance.com) - UBS réitère son conseil à Achat sur le titre avec un objectif abaissé à 55 E (au lieu de 57 E) - 26/09/2023 à 10:44 - Boursorama
Siemens Healthineers'' main segments include imaging, diagnostics, advanced therapies, and Varian. Learn what makes SEMHF stock an attractive buy.
Kenny has proven track record of driving growth at companies within the healthcare space and holds significant management and public company board experience, most recently as CEO of Meridian Bioscience As CEO Kenny managed the sale of Meridian Biosciences in an all-cash transaction valued at approximately $1.53 billion NEWPORT BEACH, Calif., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA ), a global biomedical company leading the way in innovative gastroenterology solutions, today announced the appointment of Jack Kenny, former CEO and board member of Meridian Bioscience, Inc., to its Board of Directors. Meridian Biosciences (formerly traded on Nasdaq under VIVO) is a leading global provider of diagnostic testing solutions. Meridian Biosciences was acquired on January 31, 2023 by SD Biosensor, Inc. and SJL Partners LLC in an all-cash transaction valued at approximately $1.53 billion. "I''m excited to join Biomerica''s Board and contribute to the launch and growth of the company''s groundbreaking product, inFoods ® IBS.
SSM Health and Siemens Healthineers have announced a new 10- year strategic partnership agreement focused on expanding access to high-quality care and training the next generation of health care workers. The agreement with SSM Health creates the largest geographic Siemens Healthineers strategic partnership to date. A global pioneer in medical… The post SSM Health, Siemens Healthineers Partner to Advance Health Equity and Empower Workforce Development in Underserved Communities appeared first on Insurance News | InsuranceNewsNet .
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 04.08.2023 / 17:08 CET/CEST The issuer is solely responsible for the content of this announcement. 1. Details of the person discharging managerial responsibilities / person closely associated
Siemens Healthineers AG (OTCPK:SEMHF) Q3 2023 Earnings Conference Call August 2, 2023 2:00 AM ETCompany ParticipantsMarc Koebernick - Head of Investor RelationsBernhard Montag - Chief…
Siemens Healthineers AG press release (SEMHF): Q3 Non-GAAP EPS of €0.53.Revenue of €5.2B (+0.2% Y/Y).
BERLIN (dpa-AFX) - Siemens Healthineers AG (SMMNY.PK) revealed a profit for its third quarter that increased from last yearThe company''s earnings totaled Euro445 million, or Euro0.40 per share. Th…